Hydrogel Dressing Market in Europe 2020-2024

Global Hydrogel Dressing Market in Europe 2020-2024

The author has been monitoring the global hydrogel dressing market in Europe and it is poised to grow by USD 35.17 mn during 2020-2024, progressing at a CAGR of 6% during the forecast period. The reports on global hydrogel dressing market in Europe provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current Europe market scenario, latest trends and drivers, and the overall market environment. The market is driven by strong prevalence of pressure ulcers. In addition, advances in on-demand dissolvable hydrogel dressings is anticipated to boost the growth of the global hydrogel dressing market in Europe as well.

Market Segmentation

The global hydrogel dressing market in Europe is segmented as below:

Product

Amorphous Hydrogel Dressings
Impregnated Hydrogel Dressings
Hydrogel Sheet Dressings

Geographic segmentation

Germany
UK
France
Rest of Europe

Key Trends for global hydrogel dressing market in Europe growth
This study identifies advances in on-demand dissolvable hydrogel dressings as the prime reasons driving the global hydrogel dressing market in Europe growth during the next few years.

Prominent vendors in global hydrogel dressing market in Europe
We provide a detailed analysis of around 25 vendors operating in the global hydrogel dressing market in Europe, including some of the vendors such as 3M Co., B. Braun Melsungen AG, Cardinal Health Inc., Coloplast Group, ConvaTec Group Plc, Integra LifeSciences Holdings Corp., Lohmann & Rauscher GmbH & Co. KG, McKesson Corp., Medline Industries Inc. and Smith & Nephew Plc.

The study was conducted using an objective combination of primary and secondary information including inputs from key icipants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

01: EXECUTIVE SUMMARY

02: SCOPE OF THE REPORT

Preface
Currency conversion rates for US$

03: MARKET LANDSCAPE

Market ecosystem
Market characteristics
Market segmentation analysis
Value Chain Analysis

04: MARKET SIZING

Market definition
Market sizing 2019
Market size and forecast 2019-2024

05: FIVE FORCES ANALYSIS

Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

06: MARKET SEGMENTATION BY PRODUCT

Market segmentation by product
Comparison by product
Amorphous hydrogel dressings - Market size and forecast 2019-2024
Impregnated hydrogel dressings - Market size and forecast 2019-2024
Hydrogel sheet dressings - Market size and forecast 2019-2024
Market opportunity by product

07: CUSTOMER LANDSCAPE

08: GEOGRAPHIC LANDSCAPE

Geographic segmentation
Geographic comparison
Germany - Market size and forecast 2019-2024
UK - Market size and forecast 2019-2024
France - Market size and forecast 2019-2024
Rest of Europe - Market size and forecast 2019-2024
Key leading countries
Market opportunity

09: DECISION FRAMEWORK

10: DRIVERS AND CHALLENGES

Market drivers
Market challenges

11: MARKET TRENDS

Increasing initiatives by public organizations
Ongoing healthcare reforms in France
Advances in on-demand dissolvable hydrogel dressings

12: VENDOR LANDSCAPE

Overview
Landscape disruption
Competitive scenario

13: VENDOR ANALYSIS

Vendors covered
Vendor classification
Market positioning of vendors
3M Co.
B. Braun Melsungen AG
Cardinal Health Inc.
Coloplast Group
ConvaTec Group Plc
Integra LifeSciences Holdings Corp.
Lohmann & Rauscher GmbH & Co. KG
McKesson Corp.
Medline Industries Inc.
Smith & Nephew Plc

14: APPENDIX

Research methodology
List of abbreviations
Definition of market positioning of vendors

List of Exhibits

Exhibit 01: Global healthcare supplies market
Exhibit 02: Segments of global healthcare supplies market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Vendors: Key offerings
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Regional market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Number of people aged 65 years and above in EU countries in 2005 and 2018 (in millions)
Exhibit 10: Regional market: Year-over-year growth 2020-2024 (%)
Exhibit 11: Five forces analysis 2019
Exhibit 12: Five forces analysis 2024
Exhibit 13: Bargaining power of buyers
Exhibit 14: Bargaining power of suppliers
Exhibit 15: Threat of new entrants
Exhibit 16: Threat of substitutes
Exhibit 17: Threat of rivalry
Exhibit 18: Market condition - Five forces 2019
Exhibit 19: Product - Market share 2019-2024 (%)
Exhibit 20: Comparison by product
Exhibit 21: Amorphous hydrogel dressings - Market size and forecast 2019-2024 ($ millions)
Exhibit 22: Amorphous hydrogel dressings - Year-over-year growth 2020-2024 (%)
Exhibit 23: Impregnated hydrogel dressings - Market size and forecast 2019-2024 ($ millions)
Exhibit 24: Impregnated hydrogel dressings - Year-over-year growth 2020-2024 (%)
Exhibit 25: Hydrogel sheet dressings - Market size and forecast 2019-2024 ($ millions)
Exhibit 26: Hydrogel sheet dressings - Year-over-year growth 2020-2024 (%)
Exhibit 27: Market opportunity by product
Exhibit 28: Customer landscape
Exhibit 29: Market share by geography 2019-2024 (%)
Exhibit 30: Geographic comparison
Exhibit 31: Germany - Market size and forecast 2019-2024 ($ millions)
Exhibit 32: Germany - Year-over-year growth 2020-2024 (%)
Exhibit 33: UK - Market size and forecast 2019-2024 ($ millions)
Exhibit 34: UK - Year-over-year growth 2020-2024 (%)
Exhibit 35: France - Market size and forecast 2019-2024 ($ millions)
Exhibit 36: France - Year-over-year growth 2020-2024 (%)
Exhibit 37: Rest of Europe - Market size and forecast 2019-2024 ($ millions)
Exhibit 38: Rest of Europe - Year-over-year growth 2020-2024 (%)
Exhibit 39: Key leading countries
Exhibit 40: Market opportunity
Exhibit 41: Transmission of infections
Exhibit 42: Impact of drivers and challenges
Exhibit 43: Vendor landscape
Exhibit 44: Landscape disruption
Exhibit 45: Vendors covered
Exhibit 46: Vendor classification
Exhibit 47: Market positioning of vendors
Exhibit 48: 3M Co. - Vendor overview
Exhibit 49: 3M Co. - Business segments
Exhibit 50: 3M Co. - Organizational developments
Exhibit 51: 3M Co. - Geographic focus
Exhibit 52: 3M Co. - Segment focus
Exhibit 53: 3M Co. - Key offerings
Exhibit 54: B. Braun Melsungen AG - Vendor overview
Exhibit 55: B. Braun Melsungen AG - Business segments
Exhibit 56: B. Braun Melsungen AG - Organizational developments
Exhibit 57: B. Braun Melsungen AG - Geographic focus
Exhibit 58: B. Braun Melsungen AG - Segment focus
Exhibit 59: B. Braun Melsungen AG - Key offerings
Exhibit 60: Cardinal Health Inc. - Vendor overview
Exhibit 61: Cardinal Health Inc. - Business segments
Exhibit 62: Cardinal Health Inc. - Organizational developments
Exhibit 63: Cardinal Health Inc. - Geographic focus
Exhibit 64: Cardinal Health Inc. - Segment focus
Exhibit 65: Cardinal Health Inc. - Key offerings
Exhibit 66: Coloplast Group - Vendor overview
Exhibit 67: Coloplast Group - Product segments
Exhibit 68: Coloplast Group - Organizational developments
Exhibit 69: Coloplast Group - Geographic focus
Exhibit 70: Coloplast Group - Segment focus
Exhibit 71: Coloplast Group - Key offerings
Exhibit 72: ConvaTec Group Plc - Vendor overview
Exhibit 73: ConvaTec Group Plc - Business segments
Exhibit 74: ConvaTec Group Plc - Organizational developments
Exhibit 75: ConvaTec Group Plc - Geographic focus
Exhibit 76: ConvaTec Group Plc - Segment focus
Exhibit 77: ConvaTec Group Plc - Key offerings
Exhibit 78: Integra LifeSciences Holdings Corp. - Vendor overview
Exhibit 79: Integra LifeSciences Holdings Corp. - Business segments
Exhibit 80: Integra LifeSciences Holdings Corp. - Organizational developments
Exhibit 81: Integra LifeSciences Holdings Corp. - Geographic focus
Exhibit 82: Integra LifeSciences Holdings Corp. - Segment focus
Exhibit 83: Integra LifeSciences Holdings Corp. - Key offerings
Exhibit 84: Lohmann & Rauscher GmbH & Co. KG - Vendor overview
Exhibit 85: Lohmann & Rauscher GmbH & Co. KG - Product segments
Exhibit 86: Lohmann & Rauscher GmbH & Co. KG - Organizational developments
Exhibit 87: Lohmann & Rauscher GmbH & Co. KG - Key offerings
Exhibit 88: McKesson Corp. - Vendor overview
Exhibit 89: McKesson Corp. - Business segments
Exhibit 90: McKesson Corp. - Organizational developments
Exhibit 91: McKesson Corp. - Geographic focus
Exhibit 92: McKesson Corp. - Segment focus
Exhibit 93: McKesson Corp. - Key offerings
Exhibit 94: Medline Industries Inc. - Vendor overview
Exhibit 95: Medline Industries Inc. - Product segments
Exhibit 96: Medline Industries Inc. - Organizational developments
Exhibit 97: Medline Industries Inc. - Key offerings
Exhibit 98: Smith & Nephew Plc - Vendor overview
Exhibit 99: Smith & Nephew Plc - Product segments
Exhibit 100: Smith & Nephew Plc - Organizational developments
Exhibit 101: Smith & Nephew Plc - Geographic focus
Exhibit 102: Smith & Nephew Plc - Segment focus
Exhibit 103: Smith & Nephew Plc - Key offerings
Exhibit 104: Validation techniques employed for market sizing
Exhibit 105: Definition of market positioning of vendors

Executive Summary

The following companies as the key players in the global hydrogel dressing market in Europe: 3M Co., B. Braun Melsungen AG, Cardinal Health Inc., Coloplast Group, ConvaTec Group Plc, Integra LifeSciences Holdings Corp., Lohmann & Rauscher GmbH & Co. KG, McKesson Corp., Medline Industries Inc. and Smith & Nephew Plc.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is advances in on-demand dissolvable hydrogel dressings”

According to the report, one of the major drivers for this market is the strong prevalence of pressure ulcers.

The study was conducted using an objective combination of primary and secondary information including inputs from key icipants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.